Australia markets open in 25 minutes

Aditxt, Inc. (ADTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.8023-0.0127 (-1.56%)
At close: 04:00PM EST
0.8317 +0.03 (+3.66%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous close0.8150
Open0.8150
Bid0.8100 x 1300
Ask0.8317 x 800
Day's range0.7830 - 0.8251
52-week range0.7740 - 6.7300
Volume1,924,914
Avg. volume4,323,825
Market cap21.603M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-1.8570
Earnings date13 Nov 2020
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est4.00
  • Business Wire

    Aditxt Extends the Timeline to Sign the Definitive Agreement to Acquire AiPharma Global to December 16, 2021

    RICHMOND, Va., December 02, 2021--Aditxt, Inc. ("Aditxt" or the "Company") (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today that it has entered into an amendment to its previously announced transaction agreement with AiPharma Global extending the outside date by which the parties have to execute a definitive agreement from November 30, 2021 to December 16, 2021, and to remove the $4 million termination fee from the transactio

  • Business Wire

    Aditxt Announces Pricing of $17.4 Million Firm Commitment Public Offering of Common Stock and Warrants Led by Leading Healthcare Investor

    RICHMOND, Va., December 01, 2021--Aditxt, Inc. ("Aditxt", or the "Company") (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today the pricing of an underwritten public offering of 16,575,000 units, consisting of shares of its common stock (or pre-funded warrants to purchase common stock) and warrants to purchase up to 16,575,000 shares of its common stock at a public offering price of $1.05 per unit, for aggregate gross proceeds o

  • Business Wire

    Aditxt Announces Proposed Public Offering of Common Stock and Warrants

    RICHMOND, Va., December 01, 2021--Aditxt, Inc. ("Aditxt") (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today the launch of an underwritten public offering.